Herceptin Alternatives Compared
Herceptin | Anastrozole | Tamoxifen |
|
---|
Herceptin (trastuzumab) | Anastrozole | Tamoxifen |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Breast Cancer, Breast Cancer - Metastatic, Breast Cancer - Adjuvant, Esophageal Carcinoma, Gastric Cancer. May also be prescribed off label for Salivary Gland Cancer. |
Prescription only
Anastrozole is a medication that may be used to treat postmenopausal breast cancer and works by lowering estrogen levels in the body. It is usually taken for five years and hot flushes are the most... View more |
Prescription only
Prescribed for Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Breast Cancer - Male, Breast Cancer - Palliative, McCune-Albright Syndrome, Precocious Puberty. May also be... View more |
Related suggestions Breast Cancer
Popular comparisons
|
|||||||||||||||||||||||
More about Herceptin (trastuzumab) | More about Anastrozole | More about Tamoxifen | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
No lower-cost generic available |
||||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Herceptin has an average rating of 8.8 out of 10 from a total of 10 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Anastrozole has an average rating of 5.1 out of 10 from a total of 224 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 38% reported a negative effect. |
Tamoxifen has an average rating of 5.5 out of 10 from a total of 96 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
Common side effects include:
See also: Herceptin side effects in more detail. |
See also: anastrozole side effects in more detail. |
Commonly reported side effects include:
See also: tamoxifen side effects in more detail. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Herceptin prices |
View all anastrozole prices |
View all tamoxifen prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other trastuzumab brands include: Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera | Arimidex | Soltamox | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
924 hours |
50 hours |
231 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 156 drugs are known to interact with Herceptin:
|
A total of 18 drugs are known to interact with anastrozole:
|
A total of 397 drugs are known to interact with tamoxifen:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
September 25, 1998 |
May 11, 2012 |
October 27, 2017 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.